Breaking News Instant updates and real-time market news.

BYD

Boyd Gaming

, GME

GameStop

09:40
11/23/16
11/23
09:40
11/23/16
09:40

Unusually active option classes on open November 23rd

Unusual total active option classes on open include: Boyd Gaming (BYD), GameStop (GME), Ctrip.com (CTRP), SPDR Gold Trust (GLD), Micron (MU), iShares Silver Trust (SLV), and Verizon (VZ).

BYD

Boyd Gaming

GME

GameStop

CTRP

Ctrip.com

$41.87

-0.39 (-0.92%)

GLD

SPDR Gold Trust

MU

Micron

$19.74

0.25 (1.28%)

SLV

iShares Silver Trust

VZ

Verizon

  • 23

    Nov

  • 28

    Nov

  • 05

    Dec

  • 07

    Dec

  • 21

    Dec

  • 24

    Jan

BYD Boyd Gaming

10/17/16
JPMS
10/17/16
NO CHANGE
Target $25
JPMS
Overweight
JPMorgan likes Boyd Gaming into 2017, ups target to $25
JPMorgan analyst Joseph Greff raised his price target for Boyd Gaming to $25 from $22 saying he likes the stock heading into 2017. The analyst expects Boyd's free cash flow profile to improve and he keeps an Overweight rating on the shares.
11/02/16
UGAM
11/02/16
DOWNGRADE
UGAM
Hold
Boyd Gaming downgraded to Hold from Buy at Union Gaming
09/08/16
DBAB
09/08/16
NO CHANGE
Target $25
DBAB
Buy
Deutsche sees 'considerable upside' in shares of Boyd Gaming
Deutsche Bank analyst Carlo Santarelli says shares of Boyd Gaming offer "considerable upside" from current levels. Fundamental upside exists and should only be magnified should Boyd choose to unlock its real estate value through a sale leaseback or similar structure, Santarelli tells investors in a research note. He believes that unlocking the company's real estate value could drive 30%-45% upside potential in the stock. The analyst keeps a Buy rating on Boyd with a $25 price target.
06/01/16
DBAB
06/01/16
NO CHANGE
Target $28
DBAB
Buy
MGM, Boyd deal good for all parties, says Deutsche Bank
Deutsche Bank analyst Carlo Santarelli views MGM Resorts' (MGM) acquisition of Boyd's (BYD) Borgata share as a net positive and accretive for all parties. Boyd is the biggest beneficiary as it has the "easiest accretion visibility," Santarelli tells investors in a research note. The analyst has a Buy rating on MGM with a $28 price target.
GME GameStop

11/03/16
BARD
11/03/16
NO CHANGE
Target $25
BARD
Outperform
GameStop price target lowered to $25 from $40 at Baird
Baird analyst Colin Sebastian lowered his price target on GameStop to $25 from $40 following its Q3 preannouncement. The analyst said his field checks indicated mixed pre-order levels for key holiday titles through October and he expects promotional activity to drive holiday demand. Sebastian maintained his Buy rating on GameStop shares as his rating is based on the company's long-term diversification strategy and ongoing free cash flow generation.
11/02/16
PIPR
11/02/16
DOWNGRADE
Target $23
PIPR
Neutral
GameStop cut to Neutral on game business erosion at Piper Jaffray
As previously reported, Piper Jaffray analyst Michael Olson, downgraded GameStop to Neutral from Overweight after the company pre-released a quarterly earnings miss and lowered its fiscal year guidance. This quarter will "prove to be a microcosm of the next several years," as the company's core gaming business erosion cannot be offset by growth in its new initiatives, predicted Olson, who lowered his price target on GameStop shares to $23 from $41.
11/02/16
PIPR
11/02/16
DOWNGRADE
PIPR
Neutral
GameStop downgraded to Neutral from Overweight at Piper Jaffray
11/11/16
PIPR
11/11/16
NO CHANGE
PIPR
Oct. NPD video game software sales rose 11%, says Piper Jaffray
Piper Jaffray analyst Michael Olson says October NPD video game software sales were up 11% year-over-year due to strong results from incremental launch titles, including Electronic Arts' (EA) Battlefield 1 as well as Take Two's (TTWO) Mafia III, among others. The analyst, however, views the October NPD results as "largely irrelevant" since Activision Blizzard (ATVI), EA and Take-Two already announced December quarter guidance and GameStop (GME) recently announced preliminary October quarter results. He keeps Overweight ratings on all four names.
CTRP Ctrip.com
$41.87

-0.39 (-0.92%)

09/01/16
STFL
09/01/16
NO CHANGE
STFL
Ctrip.com price target raised to $56 from $52 at Stifel
Stifel analyst George Askew says that Ctrip.com reported "strong" results and provided "solid" revenue guidance. The analyst remains upbeat on the company's fundamentals and expects its EBITDA margins to be close to 30% in coming years. He keeps a Buy rating on the shares.
10/25/16
GSCO
10/25/16
NO CHANGE
GSCO
Conviction Buy
Alibaba price target raised to $130 from $120 at Goldman
Goldman Sachs analyst Piyush Mubayi continues to think the outlook for organic growth rates in Alibaba's (BABA) China retail business remains robust and that the margin outlook for its core businesses is also intact. The analyst raised his price target on Alibaba shares to $130 from $120 and reiterates a Conviction List Buy rating on the stock, which remains his top pick in its sector. In the Chinese Internet space, the analyst also has Buy ratings on Tencent (TCEHY), Baidu (BIDU), JD.com (JD), Ctrip.com (CTRP), NetEase (NTES) and Vipshop (VIPS).
11/14/16
OPCO
11/14/16
NO CHANGE
Target $55
OPCO
Outperform
Ctrip.com pullback creates attractive buying opportunity, says Oppenheimer
Oppenheimer analyst Jed Kelly believes the recent pullback in Ctrip.com's shares creates an attractive buying opportunity. The analyst expects "solid" Q3 results, with Q4 guidance likely bracketing Street estimates. He reiterates an Outperform rating and $55 price target on the shares.
10/06/16
10/06/16
NO CHANGE

Ctrip.com Q3 net revenue forecast trending above guidance, says M Science
GLD SPDR Gold Trust

MU Micron
$19.74

0.25 (1.28%)

11/14/16
MSCN
11/14/16
NO CHANGE
MSCN
Micron Q1 revenue estimate raised above consensus at MScience
MScience raised Micron's Q1 revenue estimate above consensus driven by strong DRAM pricing.
10/24/16
BARD
10/24/16
NO CHANGE
Target $22
BARD
Outperform
Pricing data points support above consensus estimates for Micron, says Baird
Baird analyst Tristan Gerra said checks indicate further tightening in DRAM while NAND is in shortage with price increases across NAND's three major segments. The analyst believes the data points support his well above consensus 2017 estimates for Micron. Gerra reiterated his Outperform rating and $22 price target on Micron shares.
10/19/16
PACS
10/19/16
NO CHANGE
PACS
Intel data center results bode badly for several stocks, says Pacific Crest
Pacific Crest says that Intel's (INTC) data center results and commentary were "modestly disappointing," as enterprise demand for the company's data center products was "weak," according to the firm. The firm thinks that the negative enterprise results are "modestly negative for stocks with enterprise exposure, including Micron (MU), Seagate (STX) and Western Digital (WDC)."
10/05/16
STFL
10/05/16
NO CHANGE
Target $22
STFL
Buy
Micron only at start of up cycle, says Stifel
Stifel analyst Kevin Cassidy raised his price target for Micron Technology to $22 from $20, saying the company last night delivered a "solid beat" to his expectations and the consensus forecast. The company's non-GAAP EPS guidance "has some controversy" and may cause some weakness in the shares, added Cassidy. However, he would be a buyer on the weakness, citing his view that Micron's up cycle is only at its beginning. The firm keeps its Buy rating on Micron shares.
SLV iShares Silver Trust

VZ Verizon

10/24/16
10/24/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Verizon (VZ) upgraded to Buy from Hold at Drexel Hamilton with analyst Barry Sine ting valuation, and expectations for earnings acceleration driven by wireless revenue growth, Internet of Things acquisitions, and reduced losses from strategic media investments. 2. 3M (MMM) upgraded to Overweight from Equal Weight at Barclays with analyst Scott Davis saying the negative earnings revision cycle is nearing an end and the recent pullback in the shares has created an attractive entry point. 3. CarMax (KMX) upgraded to Buy from Hold at Deutsche Bank with analyst Rod Lache saying the company should benefit as the value equation shifts to used versus new cars. 4. Dick's Sporting upgraded to Outperform from Market Perform at Cowen with analyst John Kernan citing Dick's market share gains, customer satisfaction, and accelerated traffic trends, saying that they all suggest momentum in its business. 5. Kinder Morgan (KMI) upgraded to Outperform from Market Perform at BMO Capital and to Strong Buy from Outperform at Raymond James. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/27/16
JEFF
10/27/16
NO CHANGE
JEFF
Oclaro, Lumentum pullbacks a buying opportunity, says Jefferies
Jefferies analyst James Kisner attributes today's weakness in shares of Oclaro (OCLR), Lumentum (LITE) and Finisar (FNSR) to "misguided sympathy" with Infinera (INFN), which reported results last night and commented on softness at some carrier and bandwidth wholesale customers. Infinera is facing company specific issues and doesn't have exposure to China or the Verizon (VZ)metro 100G buildout, which are both major drivers for Oclaro and Lumentum, said Kisner, who recommends using today's pullback in those two names as a buying opportunity.
10/24/16
DRXL
10/24/16
UPGRADE
DRXL
Buy
Verizon upgraded to Buy on earnings acceleration at Drexel Hamilton
Drexel Hamilton analyst Barry Sine upgraded Verizon to Buy with a $54 price target citing valuation, and expectations for earnings acceleration driven by wireless revenue growth, IoT acquisitions, and reduced losses from strategic media investments.
10/24/16
DRXL
10/24/16
UPGRADE
DRXL
Buy
Verizon upgraded to Buy from Hold at Drexel Hamilton

TODAY'S FREE FLY STORIES

GM

General Motors

$39.42

0.32 (0.82%)

11:43
09/23/17
09/23
11:43
09/23/17
11:43
Periodicals
GM to eliminate shift at Tennessee SUV plant on 'moderating' sales, WSJ says »

General Motors has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.25

0.19 (0.35%)

11:34
09/23/17
09/23
11:34
09/23/17
11:34
Periodicals
Wells Fargo hires law firm to prepare CEO for Senate appearance, Reuters says »

Wells Fargo has hired law…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 03

    Oct

  • 13

    Oct

  • 22

    Oct

  • 29

    Nov

  • 15

    Jan

EADSY

Airbus

$23.06

-0.01 (-0.04%)

11:27
09/23/17
09/23
11:27
09/23/17
11:27
Periodicals
Airbus in talks to sell all or part of Premium Aerotec, Reuters says »

Airbus is said to be in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGX

Quest Diagnostics

$102.11

0.56 (0.55%)

11:06
09/23/17
09/23
11:06
09/23/17
11:06
Hot Stocks
Quest Diagnostics 'disappointed' with proposed PAMA 2018 Medicare payment rates »

Quest Diagnostics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

IRBT

iRobot

$76.14

-3.8 (-4.75%)

10:58
09/23/17
09/23
10:58
09/23/17
10:58
Periodicals
iRobot suffering after onslaught of SharkNinja cheaper models, Barron's says »

In a follow up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$69.33

0.42 (0.61%)

, SNPS

Synopsys

$80.36

0.3 (0.37%)

10:47
09/23/17
09/23
10:47
09/23/17
10:47
Periodicals
Xilinx, Synopsys are 'rising stars' amid natural evolution of AI, Barron's says »

As everyday items get…

XLNX

Xilinx

$69.33

0.42 (0.61%)

SNPS

Synopsys

$80.36

0.3 (0.37%)

CDNS

Cadence Design

$38.88

0.45 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

UTX

United Technologies

$115.01

0.51 (0.45%)

, COL

Rockwell Collins

$130.48

0.09 (0.07%)

10:42
09/23/17
09/23
10:42
09/23/17
10:42
Periodicals
Major aircraft makers, suppliers face off, Barron's says »

While United Technologies…

UTX

United Technologies

$115.01

0.51 (0.45%)

COL

Rockwell Collins

$130.48

0.09 (0.07%)

BA

Boeing

$256.45

0.41 (0.16%)

EADSY

Airbus

$23.06

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

GPRO

GoPro

$10.75

-0.19 (-1.74%)

10:33
09/23/17
09/23
10:33
09/23/17
10:33
Periodicals
Key events may create 'short squeeze' in GoPro stock, Barron's says »

GoPro, a heavily shorted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMC

Honda

$29.91

0.18 (0.61%)

, RACE

Ferrari

$113.47

-0.1 (-0.09%)

10:17
09/23/17
09/23
10:17
09/23/17
10:17
Periodicals
Honda $200,000 Acura NSX lacks Ferrari 'raw appeal,' Barron's says »

Acura, Honda's (HMC)…

HMC

Honda

$29.91

0.18 (0.61%)

RACE

Ferrari

$113.47

-0.1 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$48.16

0.19 (0.40%)

10:07
09/23/17
09/23
10:07
09/23/17
10:07
Periodicals
Oracle shares could return 20% in a year, Barron's says »

Oracle is a latecomer to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIX

Six Flags

$58.96

1.14 (1.97%)

09:59
09/23/17
09/23
09:59
09/23/17
09:59
Periodicals
Six Flags may have peaked, Barron's says »

Investors have had an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

, AVXS

AveXis

$92.11

-4.03 (-4.19%)

09:51
09/23/17
09/23
09:51
09/23/17
09:51
Periodicals
Gene therapy may be nearing 'major breakthrough,' Baron's says »

Gene therapy is rapidly…

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

AVXS

AveXis

$92.11

-4.03 (-4.19%)

RGNX

Regenxbio

$28.25

-1.15 (-3.91%)

BOLD

Audentes Therapeutics

$27.31

-0.1 (-0.36%)

VYGR

Voyager Therapeutics

$17.50

-0.22 (-1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 12

    Oct

  • 12

    Jan

  • 22

    Sep

AET

Aetna

$153.57

0.18 (0.12%)

, ANTM

Anthem

$182.86

-0.64 (-0.35%)

09:25
09/23/17
09/23
09:25
09/23/17
09:25
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AET

Aetna

$153.57

0.18 (0.12%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

CNC

Centene

$92.22

1.48 (1.63%)

CI

Cigna

$182.74

0.61 (0.33%)

HNT

Health Net

HUM

Humana

$239.09

0.45 (0.19%)

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

WCG

WellCare

$167.16

1.1 (0.66%)

AOBC

American Outdoor Brands

$15.01

-0.15 (-0.99%)

RGR

Sturm, Ruger

$51.00

-1.85 (-3.50%)

WMT

Wal-Mart

$79.53

-0.48 (-0.60%)

PEP

PepsiCo

$111.85

-0.95 (-0.84%)

TGT

Target

$58.99

0.66 (1.13%)

AAPL

Apple

$151.89

-1.5 (-0.98%)

MSFT

Microsoft

$74.41

0.2 (0.27%)

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

TWTR

Twitter

$17.61

0.03 (0.17%)

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

FB

Facebook

$170.54

-0.57 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

  • 22

    Oct

  • 24

    Oct

  • 08

    Nov

  • 16

    Nov

  • 21

    Nov

  • 29

    Nov

  • 20

    Feb

AVA

Avista

$51.40

0.1 (0.19%)

18:47
09/22/17
09/22
18:47
09/22/17
18:47
Hot Stocks
Avista receives commission decision in Oregon natural gas rate case »

Avista's natural gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

BMWYY

BMW

$34.00

0.083 (0.24%)

18:40
09/22/17
09/22
18:40
09/22/17
18:40
Periodicals
BMW to build new 8 series in Dingolfing from 2018, Reuters reports »

BMW intends to build its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$33.37

0.67 (2.05%)

18:20
09/22/17
09/22
18:20
09/22/17
18:20
Hot Stocks
Cisco completes acquisition of Springpath »

Cisco announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 22

    Sep

  • 25

    Sep

  • 26

    Sep

  • 28

    Sep

  • 29

    Sep

  • 05

    Oct

  • 06

    Oct

  • 18

    Oct

  • 19

    Oct

  • 22

    Oct

  • 15

    Nov

  • 07

    Dec

  • 11

    Dec

BMY

Bristol-Myers

$63.36

0.03 (0.05%)

18:12
09/22/17
09/22
18:12
09/22/17
18:12
Hot Stocks
Bristol-Myers announces FDA approval of Opdivo »

Bristol-Myers announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 18

    Oct

  • 26

    Oct

  • 08

    Nov

  • 09

    Nov

  • 05

    Mar

INSE

Inspired Entertainment

$13.60

0.3 (2.26%)

17:38
09/22/17
09/22
17:38
09/22/17
17:38
Hot Stocks
Inspired Entertainment COO Wilson leaving by reason of redundancy »

On September 21, Inspired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

MNOV

MediciNova

$6.18

0.3 (5.10%)

17:30
09/22/17
09/22
17:30
09/22/17
17:30
Syndicate
Breaking Syndicate news story on MediciNova »

MediciNova files $200M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

ISRG

Intuitive Surgical

$1,031.52

1.31 (0.13%)

17:25
09/22/17
09/22
17:25
09/22/17
17:25
Conference/Events
Intuitive Surgical to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

GD

General Dynamics

$205.41

-0.31 (-0.15%)

17:21
09/22/17
09/22
17:21
09/22/17
17:21
Hot Stocks
General Dynamics Electric Boat awarded $341.2M government contract modification »

General Dynamics Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHRS

Coherus Biosciences

$12.85

0.3 (2.39%)

17:19
09/22/17
09/22
17:19
09/22/17
17:19
Syndicate
Breaking Syndicate news story on Coherus Biosciences »

Coherus Biosciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

FIBK

First Interstate

$36.90

0.3 (0.82%)

17:18
09/22/17
09/22
17:18
09/22/17
17:18
Syndicate
First Interstate files to sell $250M of Class A common stock »

The shelf registration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRCIA

National Research, also tag NRCIB

$37.45

0.55 (1.49%)

, NRCIB

National Research, also tag NRCIA

$54.30

0.31 (0.57%)

17:08
09/22/17
09/22
17:08
09/22/17
17:08
Hot Stocks
National Research launches metric to measure healthcare consumer loyalty »

NRC Health launched the…

NRCIA

National Research, also tag NRCIB

$37.45

0.55 (1.49%)

NRCIB

National Research, also tag NRCIA

$54.30

0.31 (0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CC

Chemours

$51.79

-0.16 (-0.31%)

, HON

Honeywell

$141.75

0.89 (0.63%)

16:58
09/22/17
09/22
16:58
09/22/17
16:58
Hot Stocks
Chemours files appeal concerning SNAP 20 rule to regulate HFCs »

The Chemours Company (CC)…

CC

Chemours

$51.79

-0.16 (-0.31%)

HON

Honeywell

$141.75

0.89 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.